Fresenius Kabi AG Introduces Levofloxacin IV in Freeflex® Container

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi USA announced today the availability of Levofloxacin in 5% Dextrose Injection in freeflex® containers. Freeflex® is an innovative container designed for infusion solutions that has been marketed globally since 2005 and in the U.S. since 2008. Freeflex’s multilayer polyolefin film is PVC-free, plasticizer-free, non-DEHP and designed for easy handling with enhanced safety, environmental performance in mind.

Help employers find you! Check out all the jobs and post your resume.